These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 10820285

  • 21. Major histocompatibility complex class I-restricted cytotoxic T lymphocyte responses during primary simian immunodeficiency virus infection in Burmese rhesus macaques.
    Nakamura M, Takahara Y, Ishii H, Sakawaki H, Horiike M, Miura T, Igarashi T, Naruse TK, Kimura A, Matano T, Matsuoka S.
    Microbiol Immunol; 2011 Nov; 55(11):768-73. PubMed ID: 21895748
    [Abstract] [Full Text] [Related]

  • 22. Recombinant canarypox vaccine-elicited CTL specific for dominant and subdominant simian immunodeficiency virus epitopes in rhesus monkeys.
    Santra S, Schmitz JE, Kuroda MJ, Lifton MA, Nickerson CE, Lord CI, Pal R, Franchini G, Letvin NL.
    J Immunol; 2002 Feb 15; 168(4):1847-53. PubMed ID: 11823518
    [Abstract] [Full Text] [Related]

  • 23. Novel simian immunodeficiency virus CTL epitopes restricted by MHC class I molecule Mamu-B*01 are highly conserved for long term in DNA/MVA-vaccinated, SHIV-challenged rhesus macaques.
    Su J, Luscher MA, Xiong Y, Rustam T, Amara RR, Rakasz E, Robinson HL, MacDonald KS.
    Int Immunol; 2005 May 15; 17(5):637-48. PubMed ID: 15824066
    [Abstract] [Full Text] [Related]

  • 24. Definition of an epitope and MHC class I molecule recognized by gag-specific cytotoxic T lymphocytes in SIVmac-infected rhesus monkeys.
    Miller MD, Yamamoto H, Hughes AL, Watkins DI, Letvin NL.
    J Immunol; 1991 Jul 01; 147(1):320-9. PubMed ID: 1711081
    [Abstract] [Full Text] [Related]

  • 25. Simian immunodeficiency virus-specific cytotoxic T lymphocytes in rhesus monkeys: characterization and vaccine induction.
    Letvin NL, Miller MD, Shen L, Chen ZW, Yasutomi Y.
    Semin Immunol; 1993 Jun 01; 5(3):215-23. PubMed ID: 8394161
    [Abstract] [Full Text] [Related]

  • 26. Biphasic CD8+ T-Cell Defense in Simian Immunodeficiency Virus Control by Acute-Phase Passive Neutralizing Antibody Immunization.
    Iseda S, Takahashi N, Poplimont H, Nomura T, Seki S, Nakane T, Nakamura M, Shi S, Ishii H, Furukawa S, Harada S, Naruse TK, Kimura A, Matano T, Yamamoto H.
    J Virol; 2016 Jul 15; 90(14):6276-6290. PubMed ID: 27122584
    [Abstract] [Full Text] [Related]

  • 27. Eventual AIDS vaccine failure in a rhesus monkey by viral escape from cytotoxic T lymphocytes.
    Barouch DH, Kunstman J, Kuroda MJ, Schmitz JE, Santra S, Peyerl FW, Krivulka GR, Beaudry K, Lifton MA, Gorgone DA, Montefiori DC, Lewis MG, Wolinsky SM, Letvin NL.
    Nature; 2002 Jan 17; 415(6869):335-9. PubMed ID: 11797012
    [Abstract] [Full Text] [Related]

  • 28. A simian immunodeficiency virus envelope V3 cytotoxic T-lymphocyte epitope in rhesus monkeys and its restricting major histocompatibility complex class I molecule Mamu-A*02.
    Watanabe N, McAdam SN, Boyson JE, Piekarczyk MS, Yasutomi Y, Watkins DI, Letvin NL.
    J Virol; 1994 Oct 17; 68(10):6690-6. PubMed ID: 7521921
    [Abstract] [Full Text] [Related]

  • 29. Characterization of the peptide binding motif of a rhesus MHC class I molecule (Mamu-A*01) that binds an immunodominant CTL epitope from simian immunodeficiency virus.
    Allen TM, Sidney J, del Guercio MF, Glickman RL, Lensmeyer GL, Wiebe DA, DeMars R, Pauza CD, Johnson RP, Sette A, Watkins DI.
    J Immunol; 1998 Jun 15; 160(12):6062-71. PubMed ID: 9637523
    [Abstract] [Full Text] [Related]

  • 30. Direct measurement of CD8+ T cell responses in macaques infected with simian immunodeficiency virus.
    Donahoe SM, Moretto WJ, Samuel RV, Metzner KJ, Marx PA, Hanke T, Connor RI, Nixon DF.
    Virology; 2000 Jul 05; 272(2):347-56. PubMed ID: 10873778
    [Abstract] [Full Text] [Related]

  • 31. CD8(+) lymphocytes from simian immunodeficiency virus-infected rhesus macaques recognize 14 different epitopes bound by the major histocompatibility complex class I molecule mamu-A*01: implications for vaccine design and testing.
    Allen TM, Mothé BR, Sidney J, Jing P, Dzuris JL, Liebl ME, Vogel TU, O'Connor DH, Wang X, Wussow MC, Thomson JA, Altman JD, Watkins DI, Sette A.
    J Virol; 2001 Jan 05; 75(2):738-49. PubMed ID: 11134287
    [Abstract] [Full Text] [Related]

  • 32. Dynamics of Simian immunodeficiency virus-specific cytotoxic T-cell responses in tissues.
    Veazey RS, Lifson JD, Schmitz JE, Kuroda MJ, Piatak M, Pandrea I, Purcell J, Bohm R, Blanchard J, Williams KC, Lackner AA.
    J Med Primatol; 2003 Aug 05; 32(4-5):194-200. PubMed ID: 14498979
    [Abstract] [Full Text] [Related]

  • 33. Macaques infected long-term with attenuated simian immunodeficiency virus (SIVmac) remain resistant to wild-type challenge, despite declining cytotoxic T lymphocyte responses to an immunodominant epitope.
    Sharpe SA, Cope A, Dowall S, Berry N, Ham C, Heeney JL, Hopkins D, Easterbrook L, Dennis M, Almond N, Cranage M.
    J Gen Virol; 2004 Sep 05; 85(Pt 9):2591-2602. PubMed ID: 15302953
    [Abstract] [Full Text] [Related]

  • 34. A commonly recognized simian immunodeficiency virus Nef epitope presented to cytotoxic T lymphocytes of Indian-origin rhesus monkeys by the prevalent major histocompatibility complex class I allele Mamu-A*02.
    Robinson S, Charini WA, Newberg MH, Kuroda MJ, Lord CI, Letvin NL.
    J Virol; 2001 Nov 05; 75(21):10179-86. PubMed ID: 11581386
    [Abstract] [Full Text] [Related]

  • 35. Long-term control of simian immunodeficiency virus replication with central memory CD4+ T-cell preservation after nonsterile protection by a cytotoxic T-lymphocyte-based vaccine.
    Kawada M, Tsukamoto T, Yamamoto H, Takeda A, Igarashi H, Watkins DI, Matano T.
    J Virol; 2007 May 05; 81(10):5202-11. PubMed ID: 17344296
    [Abstract] [Full Text] [Related]

  • 36. Effects of cytotoxic T lymphocytes (CTL) directed against a single simian immunodeficiency virus (SIV) Gag CTL epitope on the course of SIVmac239 infection.
    Allen TM, Jing P, Calore B, Horton H, O'Connor DH, Hanke T, Piekarczyk M, Ruddersdorf R, Mothé BR, Emerson C, Wilson N, Lifson JD, Belyakov IM, Berzofsky JA, Wang C, Allison DB, Montefiori DC, Desrosiers RC, Wolinsky S, Kunstman KJ, Altman JD, Sette A, McMichael AJ, Watkins DI.
    J Virol; 2002 Oct 05; 76(20):10507-11. PubMed ID: 12239328
    [Abstract] [Full Text] [Related]

  • 37. Recombinant virus vaccine-induced SIV-specific CD8+ cytotoxic T lymphocytes.
    Shen L, Chen ZW, Miller MD, Stallard V, Mazzara GP, Panicali DL, Letvin NL.
    Science; 1991 Apr 19; 252(5004):440-3. PubMed ID: 1708168
    [Abstract] [Full Text] [Related]

  • 38. Cytotoxic T-lymphocyte responses to cytomegalovirus in normal and simian immunodeficiency virus-infected rhesus macaques.
    Kaur A, Daniel MD, Hempel D, Lee-Parritz D, Hirsch MS, Johnson RP.
    J Virol; 1996 Nov 19; 70(11):7725-33. PubMed ID: 8892893
    [Abstract] [Full Text] [Related]

  • 39. Simian immunodeficiency virus-specific cytotoxic T lymphocytes and cell-associated viral RNA levels in distinct lymphoid compartments of SIVmac-infected rhesus monkeys.
    Kuroda MJ, Schmitz JE, Seth A, Veazey RS, Nickerson CE, Lifton MA, Dailey PJ, Forman MA, Racz P, Tenner-Racz K, Letvin NL.
    Blood; 2000 Aug 15; 96(4):1474-9. PubMed ID: 10942394
    [Abstract] [Full Text] [Related]

  • 40. Analysis of Gag-specific cytotoxic T lymphocytes in simian immunodeficiency virus-infected rhesus monkeys by cell staining with a tetrameric major histocompatibility complex class I-peptide complex.
    Kuroda MJ, Schmitz JE, Barouch DH, Craiu A, Allen TM, Sette A, Watkins DI, Forman MA, Letvin NL.
    J Exp Med; 1998 May 04; 187(9):1373-81. PubMed ID: 9565630
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.